Skip to content

Reported July 22, 2026 · Before market open

Revenue$470.8MMiss by $411.7K
EPS$0.32Beat by $0.10
Revenue estimate$471.2M
EPS estimate$0.22
I am pleased with our second quarter results, which underscore the strength of our business model and the continued, disciplined execution across our operations. Looking ahead, we are reaffirming our 2026 mid-single-digit growth outlook, with a focus on realizing the substantial growth opportunities in the second half of the year and beyond.
Healthcare Services Group

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$483.5M
EPS estimate$0.22

Financials

Q2 2026

Income statement

See full
Revenue$470.8M+2.7%
Gross profit$74.8M+2,428%
Net income$22.7M+170%
EPS (diluted)$0.32+173%

Balance sheet

See full
Cash & equivalents$123.4M+49.0%
Total debt$17.7M+15.5%
Total equity$518.8M+8.8%
Total assets$820.9M+2.3%

Cash flow

See full
Operating cash flow$21.9M-24.0%
CapEx$1.6M+19.9%
Free cash flow$20.2M-26.2%

Valuation & ratios

Valuation

as of 07/29/26
See full
Market cap$1.63B+69.6%
Enterprise value$1.52B+70.6%
P/E13.3×-75.6×
P/S0.9×+0.3×

Profitability

See full
Gross margin17.1%+6.2pp
Net margin6.6%+6.0pp
FCF margin8%

Returns & leverage

See full
Return on equity24.7%+22.4pp
Debt / equity0.0×
Current ratio+0.5×

Segments

By segment

See full
Dietary$257.6M+1.9%
Environmental Services$213.2M+3.6%

Versus estimates

Full release

8-K filed July 22, 2026

View on SEC.gov

Healthcare Services Group

Reports Second Quarter Results

Delivers Strong Results

Reaffirms 2026 Growth Outlook

  • Revenue of $470.8 million.
  • Net income and diluted EPS of $22.7 million and $0.32.
  • Cash flow from operations of $21.9 million; cash flow from operations, excluding the change in payroll accrual, of $27.9 million.
  • Share repurchases of $20.9 million under previously announced $75.0 million, 12-month share repurchase plan.
  • Reaffirms 2026 mid-single-digit growth outlook.

BENSALEM, PA--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2026.

CEO Commentary

Ted Wahl, Chief Executive Officer, stated, “I am pleased with our second quarter results, which underscore the strength of our business model and the continued, disciplined execution across our operations. Looking ahead, we are reaffirming our 2026 mid-single-digit growth outlook, with a focus on realizing the substantial growth opportunities in the second half of the year and beyond.”

Second Quarter Results

  • Revenue was reported at $470.8 million.
  • Segment revenues and margins for Environmental and Dietary Services were reported at $213.2 million and 13.3% and $257.6 million and 7.5%, respectively.
  • Cost of services was reported at $396.0 million or 84.1%.
  • The Company’s goal is to manage cost of services in the 86% range.
  • SG&A was reported at $52.6 million. After adjusting for the $6.9 million increase in deferred compensation, SG&A was $45.7 million or 9.7%.
  • The Company’s goal is to manage SG&A in the 9.5% to 10.5% range, with the longer term goal of managing those costs into the 8.5% to 9.5% range.
  • Other income was reported at $8.8 million. After adjusting for the $6.9 million increase in deferred compensation, other income was $1.9 million.
  • Effective tax rate was reported at 26.8%.
  • The Company expects its 2026 effective tax rate to be approximately 25.0%.
  • Net income and diluted EPS were reported at $22.7 million and $0.32, respectively.

Balance Sheet and Liquidity

The Company’s primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. Cash flow from operations was reported at $21.9 million. After adjusting for the $6.0 million decrease in the payroll accrual, cash flow from operations was $27.9 million. As of the end of the second quarter, the Company had cash and marketable securities of $200.9 million and an unutilized $300.0 million credit facility.

Share Repurchases

In February 2026, the Company announced its plan to further accelerate the pace of its share buybacks and repurchase $75.0 million of its common stock through January 2027. In the second quarter, the Company repurchased $20.9 million of its common stock. Year-to-date, the Company has purchased $44.9 million of its common stock. The Company has 8.3 million shares remaining under its February 2026 share repurchase authorization.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, July 22, 2026, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2026. The call may be accessed via phone at 1 (833) 461-5787, Conference ID: 594377303. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

The Company will be participating in the RBC Nashville Bus Tour on August 12 in Nashville, TN. The Company will also be attending and presenting at Baird’s Global Healthcare Conference on September 15 in New York, NY. Additionally, the Company will be participating in a Non-Deal Roadshow hosted by Oppenheimer in New York, NY and Boston, MA on September 22 & 23.

About Healthcare Services Group, Inc.

Healthcare Services Group (NASDAQ: HCSG) is a leader in managing Environmental and Dietary services within the healthcare industry. With 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for its clients.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” “intend” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation, general liability and other insurance programs; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts and increased energy prices; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2025 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting cash flow from operations (excluding the change in payroll accrual), earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA excluding items impacting comparability (“Adjusted EBITDA”). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

Company Contacts:

| | | | | | | | | | | Theodore Wahl | | | | | | | | | | President and Chief Executive Officer | | | | | | | | | | | | | | | | | | | | Vikas Singh | | | | | | | | | | Executive Vice President and Chief Financial Officer | | | | | | | | | | | | | | | | | | | | Matthew J. McKee | | | | | | | | | | Chief Communications Officer | | | | | | | | | | | | | | | | | | | | 215-639-4274 | | | | | | | | | | investor-relations@hcsgcorp.com | | | | | | | | |

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)

(in thousands, except per share data)

For the Three Months EndedFor the Six Months Ended
June 30,June 30,
2026202520262025
Revenue$470,808$458,491$933,574$906,153
Operating costs and expenses:
Cost of services396,015455,533782,946835,224
Selling, general and administrative52,58549,16394,58294,129
Income (loss) from operations22,208(46,205)56,046(23,200)
Other income, net8,7954,3179,4985,206
Income (loss) before income taxes31,003(41,888)65,544(17,994)
Income tax provision (benefit)8,307(9,522)16,788(2,856)
Net income (loss)$22,696$(32,366)$48,756$(15,138)
Net income (loss) per common share
Basic$0.33$(0.44)$0.70$(0.21)
Diluted$0.32$(0.44)$0.69$(0.21)
Weighted-average common shares outstanding
Basic68,75873,16169,31173,414
Diluted69,90573,16170,47973,414

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Total Revenue$428.15M$437.81M$447.66M$458.49M$464.34M$466.68M$462.77M$470.81M
Total Cost of Revenue$364.73M$379.21M$379.69M$455.53M$367.93M$394.61M$386.93M$396.02M
Selling General and Administrative$46.89M$44.82M$44.97M$49.16M$50.54M$46.2M$42M$52.59M
Other Selling General and Administrative Expense$46.89M$44.82M$44.97M$49.16M$50.54M$46.2M$42M$52.59M
Other Investment Income and Other 60c55c$3.83M$2.2M$1.28M$4.74M$11.84M$3.05M$1.07M$9.41M
Income Before Tax$18.81M$14.81M$23.89M-$41.89M$57.31M$28.55M$34.54M$31M
Other Income Loss From Continuing Operations Before Inco E20b31$18.81M$14.81M$23.89M-$41.89M$57.31M$28.55M$34.54M$31M
Income Tax Expense-$198K$4.78M$2.89M$6.67M-$9.52M$14.36M$8.48M$8.31M
Net Income$14.03M$11.92M$17.23M-$32.37M$42.95M$31.24M$26.06M$22.7M
Eps Basic$0.19$0.17$0.23-$0.44$0.59$0.44$0.37$0.33
Eps Diluted$0.19$0.16$0.23-$0.44$0.59$0.43$0.37$0.32
Weighted Shares Basic73.7M73.8M73.7M73.2M72.2M72.4M69.9M68.8M
Weighted Shares Diluted73.9M74M74M73.2M73M73M71M69.9M

RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

(Unaudited)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Cash and Equivalents$27.06M$56.78M$64.32M$82.82M$124.39M$125.19M$136.17M$123.41M
Restricted Cash$1.08M$3.36M$65K$326K$32K$5.58M$97K$54K
Short Term Investments$76.78M$50.54M$50.5M$51.67M$53.07M$42.77M$42.44M$41.32M
Current Assets Marketable Securities Current$76.78M$50.54M$50.5M$51.67M$53.07M$42.77M$42.44M$41.32M
Accounts Receivable Net$406.5M$330.91M$337.9M$292.21M$288.52M$281.3M$299.44M$292.79M
Finance Receivables Current$51.43M$49.12M$31.63M$25.41M$31.24M$29.07M$26.68M
Total Current Assets$578.12M$556.65M$574.97M$532.29M$580.63M$576.42M$601.23M$568.53M
Non Current Assets Notes and Loans Receivable Net Noncurrent$22.91M$41.05M$36.2M$45.08M$28.35M$25.21M$20.63M$34.86M
Equipment Installment Plan Receivables Noncurrent$22.91M$41.05M$36.2M$45.08M$28.35M$25.21M$20.63M$34.86M
Goodwill$75.53M$75.53M$80.04M$80.04M$80.06M$79.8M$79.8M$85.8M
Non Current Assets Finite Lived Intangible Assets Net$10.11M$9.44M$10.02M$8.26M$7.61M$6.96M$6.32M$13.11M
Other Deferred Compensation Plan Assets$48.65M$49.64M$46.83M$51.55M$55.39M$55.91M$53M$59.14M
Total Assets$805.84M$802.77M$822.96M$802.2M$804.3M$794.25M$814.85M$820.86M
Other Self Insurance Reserve Current$21.51M$25.15M$25.93M$24.58M$23.76M$24.37M$22.48M$22.12M
Other Other Accrued Liabilities Current$25.56M$24.78M$36.59M$41.77M$37.53M$37.22M$37.72M$35.88M
Total Current Liabilities$197.2M$192.55M$198.75M$213.93M$195.64M$170.38M$193.37M$188.12M
Other Deferred Compensation Liability Classified Noncurrent$48.92M$50.01M$46.77M$51.7M$55.65M$56.28M$52.93M$59.14M
Operating Lease Liabilities Non Current$9.03M$8.03M$7.95M$7.05M$6.22M$9.66M$9.36M$11.33M
Other Non Current Liabilities$425K$385K$2.04M$1.65M$1.65M$1.59M$1.59M$809K
Total Stockholders Equity$488.75M$499.93M$514.2M$477.04M$496M$510.21M$513.77M$518.84M
Total Liabilities and Equity$805.84M$802.77M$822.96M$802.2M$804.3M$794.25M$814.85M$820.86M

1.Includes right-of-use asset depreciation of $1.4 million and $3.3 million for the three and six months ended June 30, 2026, respectively, and $2.1 million and $4.2 million for the three and six months ended June 30, 2025, respectively.

Reconciliation of GAAP cash from operations to cash flow from operations (excluding the change in payroll accrual)For the Three Months EndedFor the Six Months Ended
June 30,June 30,
2026202520262025
(in thousands)
GAAP cash from operations$21,870$28,787$65,600$56,288
Change in accrued payroll(1)6,024(20,256)(14,295)(15,665)
Cash flow from operations (excluding the change in payroll accrual)$27,894$8,531$51,305$40,623

1.The accrued payroll adjustment reflects changes in accrued payroll for the three and six months ended June 30, 2026 and 2025.The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company’s quarterly cash flow performance.

Ask the moment Healthcare Services Group reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Healthcare Services Group report Q2 2026 earnings?
Healthcare Services Group (HCSG) reported Q2 2026 earnings on July 22, 2026 before market open.
What were Healthcare Services Group's Q2 2026 revenue and EPS?
Healthcare Services Group reported revenue of $470.8M and eps of $0.32 for Q2 2026.
Did Healthcare Services Group beat estimates in Q2 2026?
Revenue missed the consensus estimate of $471.2M by $411.7K. EPS beat the consensus estimate of $0.22 by $0.10.
How did Healthcare Services Group's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.7% from $458.5M a year earlier and eps grew 52.4% from $0.21.
Where can I find Healthcare Services Group's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000731012-26-000040) and the 10-Q periodic report (0000731012-26-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.